Bio-Rad Labs Buys AbD Serotec for €53M

Bio-Rad Laboratories, Inc.

and

, a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced that it has purchased AbD Serotec, a division of MorphoSys AG, for approximately 53 million euros in cash. AbD Serotec is one of the world's leading antibody manufacturers offering over 15,000 antibodies, kits, and accessories. AbD Serotec has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom, as well as other facilities in Germany and the U.S. "We are pleased to have AbD Serotec join Bio-Rad," said Norman Schwartz, Bio-Rad President and CEO. "With AbD Serotec's comprehensive catalog of antibodies, we are able to offer our customers total assay solutions that can be validated on many of our research platforms for western blotting, multiplex protein expression, ELISA, and cell sorting."